AU2681997A - Non-invasive enzyme screen for tissue remodelling-associated conditions - Google Patents

Non-invasive enzyme screen for tissue remodelling-associated conditions

Info

Publication number
AU2681997A
AU2681997A AU26819/97A AU2681997A AU2681997A AU 2681997 A AU2681997 A AU 2681997A AU 26819/97 A AU26819/97 A AU 26819/97A AU 2681997 A AU2681997 A AU 2681997A AU 2681997 A AU2681997 A AU 2681997A
Authority
AU
Australia
Prior art keywords
associated conditions
tissue remodelling
enzyme screen
invasive
invasive enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26819/97A
Other languages
English (en)
Inventor
Michael R Freeman
Marsha A Moses
Dmitri Wiederschain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24563830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2681997(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of AU2681997A publication Critical patent/AU2681997A/en
Priority to AU61878/01A priority Critical patent/AU775537B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU26819/97A 1996-04-26 1997-04-25 Non-invasive enzyme screen for tissue remodelling-associated conditions Abandoned AU2681997A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU61878/01A AU775537B2 (en) 1996-04-26 2001-08-17 Non-invasive enzyme screen for tissue remodelling-associated conditions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63937396A 1996-04-26 1996-04-26
US08639373 1996-04-26
PCT/US1997/006909 WO1997041441A1 (en) 1996-04-26 1997-04-25 Non-invasive enzyme screen for tissue remodelling-associated conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU61878/01A Division AU775537B2 (en) 1996-04-26 2001-08-17 Non-invasive enzyme screen for tissue remodelling-associated conditions

Publications (1)

Publication Number Publication Date
AU2681997A true AU2681997A (en) 1997-11-19

Family

ID=24563830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26819/97A Abandoned AU2681997A (en) 1996-04-26 1997-04-25 Non-invasive enzyme screen for tissue remodelling-associated conditions

Country Status (6)

Country Link
US (1) US6037138A (enExample)
EP (3) EP0900381A1 (enExample)
JP (2) JP2000510949A (enExample)
AU (1) AU2681997A (enExample)
CA (1) CA2252648C (enExample)
WO (1) WO1997041441A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811995B1 (en) * 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
GB9905817D0 (en) * 1999-03-12 1999-05-05 Oxford Glycosciences Uk Ltd Methods
CA2267481A1 (en) 1999-03-30 2000-09-30 Gabriel Pulido-Cejudo Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection
AU773329B2 (en) * 1999-05-14 2004-05-20 Proteomedica Ab Materials and methods relating to disease diagnosis
AU2001258929A1 (en) 2000-05-17 2001-11-26 Leids Universitair Medisch Centrum Proteolytic enzymes in urine as diagnostic parameters in diseases involving matrix remodelling
CA2425761C (en) * 2000-10-13 2005-11-15 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
EP1832876A3 (en) * 2000-10-13 2008-04-23 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
WO2003099107A2 (en) * 2002-05-22 2003-12-04 The Cleveland Clinic Foundation Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
AU2003297099A1 (en) * 2002-12-12 2004-06-30 Manoa Medical, Inc. Percutaneous removal of sentinel lymph node using contrast imaging for identification
US20080254490A1 (en) * 2005-02-02 2008-10-16 Ramkumar Menon Salivary Protease Assays for Identifying Increased Risk of Preterm Delivery Induced by Premature Rupture of Fetal Membranes
US20070196876A1 (en) * 2006-02-17 2007-08-23 Moses Marsha A Free NGAL as a biomarker for cancer
CN101680898A (zh) * 2007-05-10 2010-03-24 霍夫曼-拉罗奇有限公司 Timp-1作为结肠直肠癌标志的用途
US10107782B2 (en) 2008-01-25 2018-10-23 ProteinSimple Method to perform limited two dimensional separation of proteins and other biologicals
US9804079B2 (en) 2012-04-19 2017-10-31 ProteinSimple Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates
US20150093757A1 (en) * 2013-09-27 2015-04-02 Protein Simple Methods. apparatus and systems for detection of total protein using capillary electrophoresis
IN202021002695A (enExample) 2020-01-21 2021-07-23

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5051361A (en) 1988-10-19 1991-09-24 Sigma Chemical Company AZT immunoassays, derivatives, conjugates and antibodies
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5340720A (en) * 1989-11-29 1994-08-23 University Of Kansas Methods of diagnosing and monitoring rheumatic diseases
AU647459B2 (en) * 1990-01-26 1994-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A method for quantitatively measuring collagenase
JP2503716B2 (ja) * 1990-04-06 1996-06-05 日東紡績株式会社 酸性ホスファタ―ゼ活性測定法
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
US5233409A (en) 1992-02-25 1993-08-03 Schwab Karl W Color analysis of organic constituents in sedimentary rocks for thermal maturity
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
CA2139128A1 (en) * 1993-04-27 1994-11-10 Celltech Therapeutics Limited Peptidyl derivatives as metalloproteinase inhibitors
WO1995015374A1 (en) * 1993-11-30 1995-06-08 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel metalloprotease and dna coding for the same
US5639656A (en) * 1994-03-31 1997-06-17 Medical College Of Hampton Road Antibodies reactive with biological markers of benign prostate hyperplasia
US5654161A (en) * 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer

Also Published As

Publication number Publication date
US6037138A (en) 2000-03-14
CA2252648A1 (en) 1997-11-06
EP1418434A3 (en) 2006-03-29
EP2060917A2 (en) 2009-05-20
EP2060917A3 (en) 2009-10-28
WO1997041441A1 (en) 1997-11-06
EP2060917B1 (en) 2014-01-01
CA2252648C (en) 2009-11-03
EP1418434A2 (en) 2004-05-12
JP2006311860A (ja) 2006-11-16
EP2060917B9 (en) 2014-06-04
EP0900381A1 (en) 1999-03-10
JP2000510949A (ja) 2000-08-22

Similar Documents

Publication Publication Date Title
AU2557397A (en) Removal of tissue
AU2824397A (en) Oval cannula assembly
AU6506698A (en) Tissue implant
AU6262698A (en) Multimodality instrument for tissue characterization
AU1842495A (en) Video based tissue oximetry
AU3734597A (en) Human kallikrein
AU3075895A (en) Endoscope
AU1562495A (en) Tissue viability monitor
AU3646597A (en) Traction-inducing compression assembly for enhanced tissue imaging
AU1071797A (en) Laryngoscope
AU6790998A (en) Suture-passing forceps
AU1007797A (en) Trackable earplug
AU5429898A (en) Glucose oxidases
AUPO244596A0 (en) Speculum
AU2681997A (en) Non-invasive enzyme screen for tissue remodelling-associated conditions
AU3011497A (en) Novel human growth factors
AU3322795A (en) Endoscope
AU4539897A (en) Shot-rock diggability monitor
AU2033397A (en) Monitor
AU3930197A (en) Detachable blood seal
AU1112099A (en) Tissue removal
AU5693398A (en) Endoscope cabinet
AU1645599A (en) Human matrilin-3
AU2316197A (en) Tissue anchor
AU8746598A (en) Tissue collector

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted